Work

Phase I pharmacokinetic (PK) and safety study of intravenous (IV) CI-1033 in patients with advanced solid tumors

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.3057

Authors: G. R. Simon, S. Olson, C. R. Garrett, I. Eiseman, M. Langevin, J. J. Mahany, D. M. Sullivan, M. G. Schlicht, R. Lush, P. Lanehan

Institutions: Pfizer (United States), Moffitt Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W46526311

Cites:

Cited by: 5

Related to: 10